Researchers at University of Tsukuba have demonstrated that during Japan's COVID-19 booster vaccination campaign, online information influenced vaccination intentions in ways similar to the initial ...

Whooping cough, a bacterial infection that can be especially dangerous for babies and young children, is on the rise. As of ...

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older ...

Most US teens have received a dose of the meningococcal vaccine, yet uptake of the first dose and completion of the booster ...

Thanks to KiwiCo for supporting this episode of SciShow! Vaccines teach your immune system to recognize pathogens, but sometimes your body needs a bit of a reminder. Hosted by: Hank Green SciShow has ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year.

A joint procurement contract between the EU and Danish manufacturer Bavarian Nordic strengthens vaccine preparedness against ...

The top vaccine chief at the Food and Drug Administration sent out a memo saying the FDA will seek a stricter review and ...

The FDA’s top vaccine regulator asserted in a staff email that the Covid vaccine caused at least 10 kids' deaths, but experts ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive final immunogenicity and safety data from Phase 2 study, VLA15-221, of Lyme disease vaccine candidate, VLA15. The results showed ...